Effect of anti-depressants on neuro-behavioural consequences following impact accelerated traumatic brain injury in rats

Indian Journal of Experimental Biology

Volumn 48, Issue 5, 2010, Pages 466-473

  Mahesh, Radhakrishnan ^a   Pandey, Dilip Kumar ^a   Katiyar, Shruti ^a   Kukade, Gaurav ^a   Viyogi, Shruti ^a   Rudra, Anjuman ^a  

^a BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

Anti depressants; Anxiety; Depression; Traumatic brain injury

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CYCLOHEXANOL DERIVATIVE; NEUROTRANSMITTER UPTAKE INHIBITOR; NORADRENALIN; SEROTONIN; VENLAFAXINE;

ACCELERATION; ANIMAL; ANIMAL BEHAVIOR; ANXIETY; ARTICLE; BRAIN INJURY; DRUG EFFECT; EXPLORATORY BEHAVIOR; FEAR; MALE; NERVE CELL PLASTICITY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; RAT; SOCIAL BEHAVIOR; STARTLE REFLEX; WISTAR RAT; BRAIN INJURIES; COMPLICATION; DRUG EFFECTS; ETIOLOGY; PSYCHOLOGY;

ACCELERATION; AMITRIPTYLINE; ANIMALS; ANTIDEPRESSIVE AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BRAIN INJURIES; BUPROPION; CITALOPRAM; CYCLOHEXANOLS; EXPLORATORY BEHAVIOR; FEAR; MALE; NEURONAL PLASTICITY; NEUROTRANSMITTER UPTAKE INHIBITORS; NOREPINEPHRINE; RATS; RATS, WISTAR; SEROTONIN; SOCIAL BEHAVIOR; STARTLE REACTION; REFLEX, STARTLE;

RATTUS;

EID: 77954282773     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Jorge RE, Robinson RG & Arndt SV, Are there symptoms that are specific for depressed mood in patients with traumatic brain injury? J Nerv Merit Dis, 181(1993) 91.
2. Jorge RE, Robinson RG & Moser D, Major depression following traumatic brain injury, Arch Gen Psychiatry, 61(2004) 42.
3. Joseph AB & Wroblewski B, Depression, anti-depressants, and traumatic brain injury, J Head Trauma Rehabil, 10 (1995) 90.
4. McIntosh TK, Neurochemical sequelae of traumatic brain injury, Cereb Brain Metab Rev, 6 (1994) 109.
5. Perera TD, Coplan JD, Lisanby SH, Lipira CM, Arif M & Carpio C, Anti-depressant-induced neurogenesis in the hippocampus of adult nonhuman primates, J Neurosci, 27 (2007) 4894.
6. Van Reekum R, Cohen T & Wong J, Can traumatic brain injury cause psychiatric disorders? J Neuropsychiatry Clin Neurosci, 12 (2000) 316.
7. Sairanen M, O'Leary OF, Knuuttila JE & Castren E, Chronic anti-depressant treatment selectively increases expression of plasticity-related proteins in the hippocampus and medial prefrontal cortex of the rat, Neuroscience, 144 (1997) 368.
8. Vouimba RM, Munoz C & Diamond DM, Differential effects of predator stress and the anti-depressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala, Stress, 9 (2006) 29.
9. Khouzam HR & Donnelly NJ, Remission of traumatic brain injury-induced compulsions during venlafaxine treatment, Gen Hosp Psychiatry, 20 (1998) 62.
10. Suarez M, Molina S, Rivarola M, & Perassi N, Effects of maternal deprivation on adrenal and behavioural responses in rats with anterodorsal thalami nuclei lesions. Life Sci, 71 (2002)1125.
11. Vink R, O'Connor CA, Nimmo AJ & Heath DL, Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats, Neurosci Lett, 336 (2003) 41.
12. Fortin S, Godbout L & Braun CM, Cognitive structure of executive deficits in frontally lesioned head trauma patients performing activities of daily living, Cortex, 39 (2003) 273.
13. Bakay L, Lee J C, Lee G C & Peng J R, Experimental cerebral concussion. I. An electron microscopic study, J Neurosurg, 47 (1977) 525.
14. Marmarou A & Shima K, Comparative studies of edema produced by fluid percussion injury with lateral and central models of injury in cats, Adv Neurol, 52 (1990) 233.
15. Shapira Y, Shohami E & Sidi A, Experimental closed head injury in rats: mechanical pathophysiologic and neurologic properties, Crit Care Med, 16 (1988) 258.
16. Boulenger JP, Huusom AK, Florea I, Baekdal T & Sarchiapone M, A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients, Curr Medical Res Opinion, 22 (2006)11.
17. Thase ME, Clayton AH, Haight BR, Thompson AH, Modell JG & Johnston JA, A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, anti-depressant efficacy, and tolerability, J Clin Psychopharmacol, 26 (2006) 42.
18. Thase ME, Haight BR, Richard N, Rockett CB, Mitton M, Modell JG, VanMeter S, Harriett AE & Wang Y, Remission rates following anti-depressant therapy with bupropion or selective serotonin re-uptake inhibitors: A meta-analysis of original data from 7 randomized controlled trials, J Clin Psychiatry, 66 (2005) 974.
19. Richelson E & Pfenning M, Blockade by anti-depressants and related compounds of biogenic amine uptake into rat brain synaptosomes: Most anti-depressants selectively block norepinephrine uptake, Eur J Pharmacol, 104 (1984) 277.
20. Foda MAA & Marmarou A, A new model of diffuse brain injury in rats; Part II: Morphological characterization, J Neurosurg, 80 (1994) 301.
21. Pandey D K, Yadav S, Mahesh R & Ramamoorthy R, Depression-like and anxiety-like behavioural aftermaths of impact accelerated traumatic brain injury in rats: A model of comorbid depression and anxiety, Behav Brain Res, 205(2009) 436.
22. Izumi J, Washizuka M & Hayashi-Kuwabara Y, Evidence for a depressive-like state induced by repeated saline injections in Fischer 344 rats, Pharmacol Biochem Behav, 57 (1997) 883.
23. Wang Dayong, Noda Yukihiro, Tsunekawa H, Masayuk Yuan Zhoub, Senzakia Koji & Nabeshima T, Behavioural and neurochemical features of olfactory bulbectomized rats resembling depression with comorbid anxiety, Behav Brain Res, 178 (2007) 262.
24. Kelly J P, Wrynn A S & Leonard B E, The olfactory bulbectomized rat as a model of depression: An update, Pharmacol Ther, 74 (1997) 299.
25. Ramamoorthy R, Radhakrishnan M & Borah M, Anti-depressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models, Behav Pharmacol, 19 (2008) 29.
26. Brady J V & Nauta W J, Subcortical mechanisms in emotional behavior: The duration of affective changes following septal and habenular lesions in the albino rat, J Comp Physiol Psychol, 48 (1955) 412.
27. Shibata S, Nakanishi H, Watanabe S & Ueki S, Effects of chronic administration of anti-depressants on mouse-killing behavior (muricide) in olfactory bulbectomized rats, Pharmacol Biochem Behav, 21 (1984) 225.
28. File SE & Hyde J R, Can social interaction be used to measure anxiety? Brit J Pharmacol, 62 (1978) 19.
29. Broekkamp C L, Rijk H W, Joly-gelo D & Lloyd K G, Major tranquilizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim induced grooming in mice, Eur J Pharmacol, 126 (1986b) 223.
30. Hemels M E, Koren G & Einarson TR, Increased use of anti-depressants in Canada: 1981-2000, Ann Pharmacother, 36 (2002) 1375.
31. McManus P, Mant A, Mitchell PB, Montgomery WS, Marley J & Auland ME, Recent trends in the use of anti-depressant drugs in Australia, 1990-1998, Med J Aust, 173 (2000) 458.
32. Ortiz A & Lozano C, El incremento en la prescripción de antidepresivos, Aten Prim, 35 (2005) 152.
33. Van Marwijk HW, Bijl D, Ader H J & De Haan M, Anti-depressant prescription for depression in general practice in The Netherlands, Pharm World Sci, 23 (2001) 46.
34. Burt D B, Zembar DJ & Niederehe G, Depression and memory impairment: a meta-analysis of the association, its pattern, and specifity, Psychol Bull, 117 (1995) 285.
35. Holsinger T, Steffens DC, Phillips C, Helms MJ, Havlik RJ, breitner JCS, Guralnik JM & Plassman BL, Head injury in early adulthood and the lifetime risk of depression, Arch Gen Psychiatry, 59 (2002) 17
36. Slotkin TA, Miller DB, Fumagalli F, McCook EC, Zhang J, Bissette G & Seidler FJ, Modeling geriatric depression in animals: Biochemical and behavioral effects of olfactory bulbectomy in young versus aged rats, J Pharmacol Exp Ther, 289 (1999) 334.
37. Ross C A, Peyser C E & Shapiro I, Delirium: Phenomenologic and etiologic subtypes, Int Psychogeriatrics, 3 (1991) 325.
38. Van Riezen H & Leonard BE, Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats, Pharmacol Ther, 47 (1990) 21.
39. King F A, Effects of amygdaloid lesions upon septal hyperemotionality in the rat, J Nervous Mental Disease, 126 (1958) 57.
40. Raitt J R, Nelson JW & Tye A, Effect of chlorpromazine on septal hyperactivity in the rat, J Pharmac Chemother, 17 (1961) 473.
41. Mayeux R, Stern Y & Sano M, The relationship of serotonin to depression in Parkinson's disease, Mov Disord, 3 (1988) 237.
42. Koponen S, Taiminen T, Portin R, Himanen L, Isoniemi H, Hinkka S & Tenovuo O, Axis I & II psychiatric disorders after traumatic brain injury: a 30-year follow-up study, Am J Psychiatry, 159 (2002) 1315.
43. Michael A. Jenike & Allen D. Brandon, Obsessive-compulsive disorder and head trauma: A rare association, J Anxiety Disorder 4 (1988) 353.
44. Treit D, Pineal JPJ & Fibiger H C, Conditioned defensive burying. A new paradigm for the study of anxiolytic agents, Pharm Biochem Behav, 15 (1981) 619.
45. 1A receptor subtype mediates the effect of fluvoxamine, a selective serotonin re-uptake inhibitor, on marble burying behaviour in mice, Jpn J Pharmacol, 68 (1995) 65.
46. Kontinen V, Kauppila T & Paananen S, Behavioural measures of depression and anxiety in rats with spinal nerve ligation-induced neuropathy, Pain, 80 (1999) 341.
47. Vink R, O'Connor CA, Nimmo AJ & Heath DL, Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats, Neurosci Lett, 336 (2003) 41.
48. Mollar HJ, Are all anti-depressants the same, J Clin Pschychiatry, 61 (2000) 24.
49. Arjan B, Cathy L, Nicolaas E & Deutz P, Anxiogenic and depressive-like effects, but no cognitive deficits, after repeated moderate tryptophan depletion in the rats, J Psychopharmacol, 16 (2002) 39.